GlaxoSmithKline’s (GSK) outgoing CEO, Sir Andrew Witty, reassured investors about the possible impact of a generic competitor to its blockbuster respiratory drug Advair in the US this year.

GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty ... the company said. Witty and chairman Sir Philip Hampton both emphasised the importance of ...

One user said he's glad that the killer is still on the loose and not caught. “Sir Andrew Witty needs to be killed next,” one user said. "you just made the list," another wrote. In his speech ...

Sir Andrew Witty spoke to analysts as the firm reported mixed results, just weeks after the shooting of Brian Thompson brought attention to the industry. Some customers responded to the killing by ...